BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20345351)

  • 1. Herbal interactions with anticancer drugs: mechanistic and clinical considerations.
    Yang AK; He SM; Liu L; Liu JP; Wei MQ; Zhou SF
    Curr Med Chem; 2010; 17(16):1635-78. PubMed ID: 20345351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of herbal products on the metabolism and transport of anticancer agents.
    He SM; Yang AK; Li XT; Du YM; Zhou SF
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1195-213. PubMed ID: 20701553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herb-drug interactions and mechanistic and clinical considerations.
    Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
    Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical herbal interactions with conventional drugs: from molecules to maladies.
    Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
    Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metabolism-mediated herb-drug interactions.
    Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
    Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters.
    Meng Q; Liu K
    Curr Drug Metab; 2014; 15(8):791-807. PubMed ID: 25705905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes.
    Block KI; Gyllenhaal C
    Integr Cancer Ther; 2002 Mar; 1(1):83-9. PubMed ID: 14664751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for interaction of kava and St. John's wort with drugs.
    Singh YN
    J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herb-drug interactions in oncology: focus on mechanisms of induction.
    Meijerman I; Beijnen JH; Schellens JH
    Oncologist; 2006; 11(7):742-52. PubMed ID: 16880233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal.
    Wilson V; Maulik SK
    Curr Drug Metab; 2018; 19(5):443-453. PubMed ID: 29086684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical drugs that interact with St. John's wort and implication in drug development.
    Di YM; Li CG; Xue CC; Zhou SF
    Curr Pharm Des; 2008; 14(17):1723-42. PubMed ID: 18673195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based management of herb-drug interaction in cancer chemotherapy.
    Cheng CW; Fan W; Ko SG; Song L; Bian ZX
    Explore (NY); 2010; 6(5):324-9. PubMed ID: 20832765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADME properties of herbal medicines in humans: evidence, challenges and strategies.
    He SM; Chan E; Zhou SF
    Curr Pharm Des; 2011; 17(4):357-407. PubMed ID: 21385154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment.
    Ziemann J; Lendeckel A; Müller S; Horneber M; Ritter CA
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1237-1248. PubMed ID: 31154477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.